Pfizer Offered $99 Billion In AstraZeneca Bid - Presented by: The Aol. On Network

Pfizer confirmed today that it had asked AstraZeneca to consider a merger, and been rebuffed. Under U.K. law, it had to disclose the offer and went public with a $98.7 billion offer to buy the London-based drug maker. The deal will be 70% cash and 30% stock, and will provide Pfizer with a way to use funds it has kept out of the U.S. without paying U.S. taxes. The deal would also allow Pfizer to lower its tax rate by creating a holding company in the U.K.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
FTR $ 6.7915 0.85 ▲ 14.34%
WIN $ 11.9525 1.42 ▲ 13.51%
SIRI $ 3.395 0.02 ▲ 0.44%
T $ 36.57 0.92 ▲ 2.58%
CTL $ 39.31 1.60 ▲ 4.24%
RAD $ 6.52 0.17 ▼ 2.54%
AAPL $ 98.34 0.68 ▼ 0.69%
BAC $ 15.449 0.05 ▼ 0.33%

As of 7/29/2014, 11:39 AM
More Most Active